Vraylar 3 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9P4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,093
Award facts
- Contract value 100% obligated
- $41,093.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,093.35 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Vraylar 3 mg capsules (30-count units). This firm fixed-price delivery order, which concludes on November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. Vraylar, a neurological treatment medication, falls within the company's extensive portfolio of pharmaceutical deliveries under the DLA Troop Support Medical prime vendor contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the company's ongoing role in supplying essential pharmaceutical products to federal defense and veteran healthcare systems through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DR26F9P4E?
SPE2DR26F9P4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F9P4E worth?
The government has obligated $41,093 on SPE2DR26F9P4E.
Is contract SPE2DR26F9P4E an order under another contract?
Yes. SPE2DR26F9P4E is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P4E competed?
The extent of competition for SPE2DR26F9P4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award